Abstract
The serine protease granzyme B (GrB) is a key effector molecule in cell-mediated immunity, released by cytotoxic lymphocytes (CLs) to induce cell death in neoplastic or virus-infected cells. The ability to detect and measure GrB activity is important for understanding CLs. Unfortunately, such analyses are complicated by significant differences in the substrate specificities of human and mouse GrB, which is reflected by their different activities on commonly used peptide substrates. Here, we present methods for the detection of active human and mouse GrB in extracts from primary cells, and evaluate the sensitivity of the various substrates and inhibitors. Mouse splenocytes produce approximately 120-fold more GrB than similarly activated human cells, which allows the use of the hGrB substrate IETD-AFC to follow mouse GrB activity despite its unfavourable kinetic properties.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Odake, S., Kam, C.M., Narasimhan, L. et al. (1991) Human and murine cytotoxic T lymphocyte serine proteases: subsite mapping with peptide thioester substrates and inhibition of enzyme activity and cytolysis by isocoumarins, Biochemistry 30, 2217–2227.
Kaiserman, D., Bird, C.H., Sun, J. et al. (2006) The major human and mouse granzymes are structurally and functionally divergent, J Cell Biol 175, 619–630.
Adrain, C., Murphy, B.M., Martin, S.J. (2005) Molecular ordering of the caspase activation cascade initiated by the cytotoxic T lymphocyte/natural killer (CTL/NK) protease granzyme B, J Biol Chem 280, 4663–4673.
Barry, M., Heibein, J.A., Pinkoski, M.J. et al. (2000) Granzyme B short-circuits the need for caspase 8 activity during granule-mediated cytotoxic T-lymphocyte killing by directly cleaving Bid, Mol Cell Biol 20, 3781–3794.
Davis, J.E., Sutton, V.R., Smyth, M.J. et al. (2000) Dependence of granzyme B-mediated cell death on a pathway regulated by Bcl-2 or its viral homolog, BHRF1, Cell Death Differ 7, 973–983.
Sutton, V.R., Davis, J.E., Cancilla, M. et al. (2000) Initiation of apoptosis by granzyme B requires direct cleavage of bid, but not direct granzyme B-mediated caspase activation, J Exp Med 192, 1403–1414.
Sun, J., Bird, C.H., Buzza, M.S. et al. (1999) Expression and purification of recombinant human granzyme B from Pichia pastoris, Biochem Biophys Res Commun 261, 251–255.
Willoughby, C.A., Bull, H.G., Garcia-Calvo, M. et al. (2002) Discovery of potent, selective human granzyme B inhibitors that inhibit CTL mediated apoptosis, Bioorg Med Chem Lett 12, 2197–2200.
Pardo, J., Wallich, R., Ebnet, K. et al. (2007) Granzyme B is expressed in mouse mast cells in vivo and in vitro and causes delayed cell death independent of perforin, Cell Death Differ 14, 1768–1779.
Sun, J., Whisstock, J.C., Harriott, P. et al. (2001) Importance of the P4’ residue in human granzyme B inhibitors and substrates revealed by scanning mutagenesis of the proteinase inhibitor 9 reactive center loop, J Biol Chem 276, 15177–15184.
Heusel, J.W., Wesselschmidt, R.L., Shresta, S. et al. (1994) Cytotoxic lymphocytes require granzyme B for the rapid induction of DNA fragmentation and apoptosis in allogeneic target cells, Cell 76, 977–987.
Prakash, M.D., Bird, C.H., and Bird, P.I. (2009) Active and zymogen forms of granzyme B are constitutively released from cytotoxic lymphocytes in the absence of target cell engagement, Immunol Cell Biol 87, 249–254.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Stewart, S.E., Mangan, M.S.J., Bird, P.I., Kaiserman, D. (2012). Detection of Human and Mouse Granzyme B Activity in Cell Extracts. In: Ashman, R. (eds) Leucocytes. Methods in Molecular Biology, vol 844. Humana Press. https://doi.org/10.1007/978-1-61779-527-5_18
Download citation
DOI: https://doi.org/10.1007/978-1-61779-527-5_18
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-61779-526-8
Online ISBN: 978-1-61779-527-5
eBook Packages: Springer Protocols